Callan JMB Announces Participation in the DealFlow Discovery Conference on January 28-29, 2026
Rhea-AI Summary
Callan JMB (NASDAQ:CJMB) will participate in the DealFlow Discovery Conference on January 28-29, 2026 at The Borgata, Atlantic City, NJ. The company is scheduled to present on Wednesday, January 28 at 3:00pm in Room #3. Callan JMB provides fulfillment, storage, monitoring, and cold chain logistics services for healthcare and emergency management agencies. For attendance or media queries, contact your DealFlow representative or email CallanJMB@kcsa.com.
Positive
- None.
Negative
- None.
News Market Reaction – CJMB
In the Jan 20 session, CJMB declined 18.21%, reflecting a significant negative market reaction. Argus tracked a trough of -20.2% from its starting point during tracking. Our momentum scanner triggered 19 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 15 | Strategic revenue deal | Positive | +275.0% | Teaming agreement with Attune targeting multi‑year revenue sharing. |
| Jan 12 | Strategic pivot | Positive | +3.0% | Pivot to GLP‑1 cold‑chain infrastructure and facility retrofitting. |
| Nov 14 | Earnings and update | Neutral | +3.6% | Q3 2025 results with higher revenue but wider losses and updates. |
| Nov 13 | Facility agreement | Positive | -9.2% | Preliminary agreement to install oral drug delivery equipment. |
| Nov 10 | Business expansion | Positive | -2.5% | Expansion into food sampling logistics with AI‑enabled partner. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news has produced large upside reactions on major strategic wins but mixed responses to broader expansion announcements, with three aligned and two divergent moves.
Over recent months, Callan JMB announced several strategic shifts and partnerships. On Nov 10, 2025, it expanded into food sampling logistics. On Nov 13, 2025, it agreed to add oral drug delivery equipment at its Texas facility. Q3 2025 results on Nov 14, 2025 showed modest revenue with wider losses. In January 2026, it pivoted toward GLP‑1 cold‑chain infrastructure and signed a teaming agreement with Attune Biotech, targeting $50–$75 million in combined revenue over 5 years.
Key Terms
cold chain logistics technical
nasdaq financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
SPRING BRANCH, Texas, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB), (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its participation in the DealFlow Discovery Conference on January 28-29, 2026.
DealFlow Discovery Conference
Dates: January 28-29, 2026
Location: The Borgata, Atlantic City, NJ
Presentation Details: Wednesday, January 28 at 3:00pm, in Room #3
For more information, please contact your DealFlow representative or email KCSA Strategic Communications at CallanJMB@kcsa.com.
About Callan JMB Inc.
Callan JMB Inc. is a vertically integrated logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services to secure medical materials and protect patients and communities with compliant, safe, and effective medicines. Our combined expertise in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance and emergency preparedness is unparalleled in the industry. We offer a gold standard in client experience with customizable interfaces, next-level reliability in shipping and environmental sustainability in our specialty packaging.
Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
CallanJMB@kcsa.com
212.896.1254
